Table 2.
HbA1c Model 3
| WK | PLA | 0.25 mg LY | 0.50 mg LY | 0.75 mg LY | 1 mg LY | 1.5 mg LY | 2 mg LY | 3 mg LY | Sitagliptin |
|---|---|---|---|---|---|---|---|---|---|
| 2 | 0 | -0.49 | -0.49 | -0.49 | -0.49 | -0.49 | -0.49 | -0.49 | -0.49 |
| 4 | 0 | -0.59 | -0.59 | -0.59 | -0.59 | -0.59 | -0.59 | -0.59 | -0.59 |
| 8 | 0 | -0.65 | -0.65 | -0.65 | -0.65 | -0.65 | -0.65 | -0.65 | -0.65 |
| 12 | 0 | -0.70 | -0.70 | -0.70 | -0.70 | -0.70 | -0.70 | -0.70 | -0.70 |
| 26 | 0 | -0.77 | -0.77 | -0.77 | -0.77 | -0.77 | -0.77 | -0.77 | -0.77 |
| 39 | 0 | -0.79 | -0.79 | -0.79 | -0.79 | -0.79 | -0.79 | -0.79 | -0.79 |
| 52 | 0 | -0.80 | -0.80 | -0.80 | -0.80 | -0.80 | -0.80 | -0.80 | -0.80 |
LY, LY2189265; PLA, placebo; WK, week.